By Jeff Clark, 7PSolutions, LLC
One thing I've learned, is despite all of the investments mentioned above, there is still a large gap in the knowledge or training of those providing the day-to-day operations and the monitoring or enforcement of any quality management system (if there is a quality management system in place at all). To make sure all stakeholders in the climate-controlled supply chain gain a unified understanding of your quality goals, there are several important questions you must answer.
By Dr. Lynne Murdoch, Bioquell UK Ltd Biological indicators (BIs) have become the industry standard for verification of hydrogen peroxide vapor (HPV) decontamination efficacy. This white paper discusses BIs for use with HPV and some of the factors associated with inconsistent performance of BIs used to assess HPV biodecontamination cycles.
By Paul Dupont, Ropack Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. In 2010, blister represented 17% of the global market, and recorded $8.1B in revenue, according to Pharmaceutical Packaging Industry — 2011 Yearbook. GBI Research.
By Britt Reid, Infinity QS Customer complaints are a part of doing business. That information you receive from people who spend money with your organization is giving you invaluable feedback. They care enough to say something. Just keep in mind the customers who do not say anything and take their business elsewhere. They are important, too.
INTERPHEX is the leading annual pharmaceutical and biopharmaceutical trade show, taking place in New York on April 23 to 25, 2013. Key decision makers will find the networking opportunities, products, services, and information they need to ensure quality and to maximize the efficiency, agility, and flexibility that solve manufacturing and supply chain problems. INTERPHEX is where intelligence and passion intersect with the full spectrum of industry products and services to create new insights and innovation. Learn more.
By Todd Daviau, Ph.D., CoreRX, Inc. Very few businesses have as specialized a set of needs as those in the pharmaceutical sector. The combination of huge product development costs, large amounts of data, and intense regulatory control makes it critical for companies to have needed information as soon as possible in order to meet a varied and closely monitored set of business processes.
By Alex Verayo, Terra Universal As cleanrooms grow in size and sophistication, energy demands go up significantly. Even worse, 24/7/365 operation puts substantial particulate loads on filters, increasing maintenance costs, and possibly causing unpredictable — and expensive — cleanroom maintenance shutdowns.